Overall, we demonstrated the SFN induced up-regulation of cyclin D2 in prostate cancer cells, and examined SFN as an epigenetic modulator by altering methylation status in the cyclin D2 promoter region. This evidence concerns the gene SFN and Familial prostate cancer.